FR2392978A2 - Naphtalimides substitues utilisables comme medicaments - Google Patents

Naphtalimides substitues utilisables comme medicaments

Info

Publication number
FR2392978A2
FR2392978A2 FR7815612A FR7815612A FR2392978A2 FR 2392978 A2 FR2392978 A2 FR 2392978A2 FR 7815612 A FR7815612 A FR 7815612A FR 7815612 A FR7815612 A FR 7815612A FR 2392978 A2 FR2392978 A2 FR 2392978A2
Authority
FR
France
Prior art keywords
naphthalimides
substitute
medicinal products
medicinal
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7815612A
Other languages
English (en)
Other versions
FR2392978B2 (fr
Inventor
Miguel Fernandez Brana
Antonio Martinez Sanz
Rafael Perez Alvarez-Ossorio
Cristobal Martinez Roldan
Cristina Roldan Fernand Gamboa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Made SA
Original Assignee
Laboratorios Made SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Made SA filed Critical Laboratorios Made SA
Publication of FR2392978A2 publication Critical patent/FR2392978A2/fr
Application granted granted Critical
Publication of FR2392978B2 publication Critical patent/FR2392978B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Naphtalimides de synthèse répondant à la formule générale :
FR7815612A 1977-06-04 1978-05-25 Naphtalimides substitues utilisables comme medicaments Granted FR2392978A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES459497A ES459497A1 (es) 1977-06-04 1977-06-04 Un metodo para la preparacion industrial de naftalimidas y sus derivados.

Publications (2)

Publication Number Publication Date
FR2392978A2 true FR2392978A2 (fr) 1978-12-29
FR2392978B2 FR2392978B2 (fr) 1982-07-02

Family

ID=8473948

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7815612A Granted FR2392978A2 (fr) 1977-06-04 1978-05-25 Naphtalimides substitues utilisables comme medicaments

Country Status (8)

Country Link
US (1) US4204063A (fr)
JP (2) JPS5439076A (fr)
AR (1) AR216945A1 (fr)
CH (1) CH634483A5 (fr)
DE (1) DE2823987A1 (fr)
ES (1) ES459497A1 (fr)
FR (1) FR2392978A2 (fr)
GB (2) GB1602683A (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125439A2 (fr) * 1983-04-01 1984-11-21 Warner-Lambert Company 1,8-Naphtalimides 3,6-disubstituées, leurs procédés de préparation et leur application
WO1991009850A1 (fr) * 1989-12-21 1991-07-11 Knoll Aktiengesellschaft Naphtalimides n-substitues, leur fabrication et utilisation
WO1992017454A1 (fr) * 1991-03-27 1992-10-15 The Du Pont Merck Pharmaceutical Company Bis-naphtalimides contenant des linkers amide et thioamide et utilises comme agents anticancereux
WO1992021673A1 (fr) * 1991-05-28 1992-12-10 Syntex (U.S.A.) Inc. Nouvelles azabicyclobenzisoquinoleines
EP0536208A1 (fr) * 1990-06-26 1993-04-14 Research Corporation Technologies, Inc. Agents anticancereux a base de 1,2-dihydro-3h-dibenzisoquinoline-1,3-diones
WO1994006771A1 (fr) * 1992-09-11 1994-03-31 Research Corporation Technologies, Inc. 1,2 DYHYDRO-3-H-DIBENZ(de,h) ISOQUINOLINE 1,3-DIONES ET LEUR UTILISATION EN TANT QU'AGENTS ANTICANCEREUX
US5635506A (en) * 1990-06-26 1997-06-03 Research Corporation Technologies, Inc. 1, 2-dihydro-3H-dibenzisoquinoline-1,3-dione anticancer agents
WO2000032577A2 (fr) * 1998-11-25 2000-06-08 Merck Patent Gmbh Benzo[de]isoquinoline-1,3-diones substituees
EP1539150A1 (fr) * 2002-07-08 2005-06-15 Chemgenex Pharmaceuticals Limited Synthese de naphtalimides, y compris d'amonafides, et preparations pharmaceutiques les contenant

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614820A (en) * 1983-04-01 1986-09-30 Warner-Lambert Co. 3,6-disubstituted-1,8-naphthalimides
US5183821A (en) * 1983-09-19 1993-02-02 Laboratories Knoll, S.A. Method for treating leukemias using N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide for treating leukemias and solid tumors
DE3604827A1 (de) * 1986-02-15 1987-08-20 Bayer Ag Elektrophotographische toner
JPH0228365Y2 (fr) * 1986-04-22 1990-07-30
JPS6344707U (fr) * 1986-09-09 1988-03-25
DE3635711A1 (de) * 1986-10-21 1988-04-28 Knoll Ag 5-nitrobenzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung
DE3707651A1 (de) * 1987-03-10 1988-09-22 Knoll Ag Bis-naphthalimide, ihre herstellung und verwendung
DE8715181U1 (fr) * 1987-10-17 1987-12-03 Ledermann Gmbh + Co, 7240 Horb, De
US5420137A (en) * 1989-07-11 1995-05-30 Knoll Ag Amonafide salts
DE3922771A1 (de) * 1989-07-11 1991-01-24 Knoll Ag Amonafide-salze
CA2030129A1 (fr) * 1989-11-29 1991-05-30 Thomas Saupe 1,8-napthalenedicarboximides utilises comme antidotes
FR2673944B1 (fr) * 1991-03-13 1995-03-10 Sanofi Elf Derives de l'1,8-naphtalimide, leur procede de preparation et les compositions pharmaceutiques les contenant.
JPH07581U (ja) * 1993-05-31 1995-01-06 株式会社遠藤製作所 浴槽用浄水器
ATE315397T1 (de) * 1996-10-21 2006-02-15 Allelix Biopharma Neurotrophin antagoniste zur behandlung von der epilepsie, alzheimer'schen krankheit und schmerzen
US6468990B1 (en) 1999-05-17 2002-10-22 Queen's University At Kingston Method of inhibiting binding of nerve growth factor to p75 NTR receptor
US6492380B1 (en) * 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
US20050239816A1 (en) * 2002-04-22 2005-10-27 Xanthus Life Sciences, Inc. Amonafide salts
US6693198B2 (en) * 2002-04-22 2004-02-17 Xanthus Life Sciences, Inc. Amonafide salts
AU2005209845A1 (en) * 2004-01-30 2005-08-18 Chemgenex Pharmaceuticals, Inc. Naphthalimide dosing by N-acetyl transferase genotyping
BRPI0510719A (pt) * 2004-05-05 2007-11-20 Unibioscreen Sa derivados de naftalimida, composição farmacêutica, uso e método de preparação dos mesmos
AU2005249593A1 (en) * 2004-06-04 2005-12-15 Chemgenex Pharmaceuticals Inc. Methods of treating cellular proliferative disease using naphthalimide and PARP-1 inhibitors
CA2622571A1 (fr) 2005-09-15 2007-03-22 Painceptor Pharma Corporation Methodes permettant de moduler l'activite induite par la neurotrophine
JP6132915B2 (ja) * 2012-08-27 2017-05-24 ユニバーシティ オブ テネシー リサーチ ファウンデーション Ｌｐａ２受容体特異的安息香酸誘導体

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1557945A (fr) * 1967-01-30 1969-02-21
DE2423547A1 (de) * 1974-05-15 1975-12-04 Hoechst Ag Basische farbstoffe, verfahren zu ihrer herstellung und ihre verwendung
FR2279396A1 (fr) * 1974-07-25 1976-02-20 Made Labor Sa Naphtalimides substitues

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330834A (en) * 1967-07-11 Naphthalimide whitening agents anb method of making same
US1796012A (en) * 1928-04-12 1931-03-10 Gen Aniline Works Inc Amino-naphthalimido-sulphonic acid compounds and process of preparing same
GB309552A (en) 1928-04-12 1930-06-26 Ig Farbenindustrie Ag Manufacture of acid wool dyestuffs
US1886797A (en) * 1928-05-18 1932-11-08 Gen Aniline Works Inc Naphthalimide dyestuffs and process of preparing them
DE530906C (de) * 1929-07-02 1931-08-01 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von sauren Wollfarbstoffen
US3625947A (en) * 1957-01-30 1971-12-07 Nippon Kayaku Kk N heterocyclic ethyl naphthalimides
GB1003083A (en) * 1961-01-21 1965-09-02 Toshiyasu Kasai Novel 4-alkoxynaphthalimides
US3310564A (en) * 1961-01-21 1967-03-21 Kasai Toshiyasu Novel 4-alkoxy naphthalimides
GB962019A (en) * 1961-04-12 1964-06-24 Mitsubishi Chem Ind Naphthalimide optical whitening agents
AT257528B (de) * 1964-08-08 1967-10-10 Bayer Ag Aufhellungsmittel
US3308127A (en) * 1964-08-24 1967-03-07 Mitsubishi Chem Ind Process for the production of naphthalic acid derivatives
GB1342350A (en) * 1969-12-30 1974-01-03 Sumitomo Chemical Co Naphthalimide derivatives
DE2423548C2 (de) * 1974-05-15 1984-08-23 Hoechst Ag, 6230 Frankfurt Verfahren zur Herstellung von 4-Amino1,8-naphthalimid-Verbindungen
GB1435238A (en) * 1974-07-24 1976-05-12 Made Labor Sa Substituted naphthalimides and processes for their preparation
JPS5116674A (en) * 1974-08-01 1976-02-10 Made Labor Sa Nafutaruimidoruino seizoho
JPS5851024B2 (ja) * 1975-05-26 1983-11-14 帝人株式会社 ユウシヨクカゴウブツノセイゾウホウ
GB1520944A (en) * 1975-06-12 1978-08-09 Teijin Ltd Quinoline derivatives for use als colouring agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1557945A (fr) * 1967-01-30 1969-02-21
DE2423547A1 (de) * 1974-05-15 1975-12-04 Hoechst Ag Basische farbstoffe, verfahren zu ihrer herstellung und ihre verwendung
FR2279396A1 (fr) * 1974-07-25 1976-02-20 Made Labor Sa Naphtalimides substitues

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125439A3 (en) * 1983-04-01 1985-12-04 Warner-Lambert Company 3,6-disubstituted-1,8-naphthalimides and methods for their production and use
EP0125439A2 (fr) * 1983-04-01 1984-11-21 Warner-Lambert Company 1,8-Naphtalimides 3,6-disubstituées, leurs procédés de préparation et leur application
WO1991009850A1 (fr) * 1989-12-21 1991-07-11 Knoll Aktiengesellschaft Naphtalimides n-substitues, leur fabrication et utilisation
EP0536208A4 (en) * 1990-06-26 1993-05-05 Research Corporation Technologies, Inc. 1,2-dihydro-3h-dibenzisoquinoline-1,3-dione anticancer agents
US5635506A (en) * 1990-06-26 1997-06-03 Research Corporation Technologies, Inc. 1, 2-dihydro-3H-dibenzisoquinoline-1,3-dione anticancer agents
EP0536208A1 (fr) * 1990-06-26 1993-04-14 Research Corporation Technologies, Inc. Agents anticancereux a base de 1,2-dihydro-3h-dibenzisoquinoline-1,3-diones
WO1992017454A1 (fr) * 1991-03-27 1992-10-15 The Du Pont Merck Pharmaceutical Company Bis-naphtalimides contenant des linkers amide et thioamide et utilises comme agents anticancereux
WO1992021673A1 (fr) * 1991-05-28 1992-12-10 Syntex (U.S.A.) Inc. Nouvelles azabicyclobenzisoquinoleines
WO1994006771A1 (fr) * 1992-09-11 1994-03-31 Research Corporation Technologies, Inc. 1,2 DYHYDRO-3-H-DIBENZ(de,h) ISOQUINOLINE 1,3-DIONES ET LEUR UTILISATION EN TANT QU'AGENTS ANTICANCEREUX
WO2000032577A2 (fr) * 1998-11-25 2000-06-08 Merck Patent Gmbh Benzo[de]isoquinoline-1,3-diones substituees
WO2000032577A3 (fr) * 1998-11-25 2000-09-21 Merck Patent Gmbh Benzo[de]isoquinoline-1,3-diones substituees
EP1539150A1 (fr) * 2002-07-08 2005-06-15 Chemgenex Pharmaceuticals Limited Synthese de naphtalimides, y compris d'amonafides, et preparations pharmaceutiques les contenant
EP1539150A4 (fr) * 2002-07-08 2006-10-11 Chemgenex Pharmaceuticals Inc Synthese de naphtalimides, y compris d'amonafides, et preparations pharmaceutiques les contenant
EP2305257A1 (fr) * 2002-07-08 2011-04-06 ChemGenex Pharmaceuticals, Inc. Sels d'amonafide et compositions les contenant

Also Published As

Publication number Publication date
FR2392978B2 (fr) 1982-07-02
GB1602683A (en) 1981-11-11
JPS5439076A (en) 1979-03-24
US4204063A (en) 1980-05-20
DE2823987A1 (de) 1978-12-07
GB1602684A (en) 1981-11-11
CH634483A5 (fr) 1983-02-15
AR216945A1 (es) 1980-02-15
DE2823987C2 (fr) 1990-08-02
JPS5835995B2 (ja) 1983-08-05
ES459497A1 (es) 1978-04-16
JPS56103166A (en) 1981-08-18

Similar Documents

Publication Publication Date Title
FR2392978A2 (fr) Naphtalimides substitues utilisables comme medicaments
FR2370051A1 (fr) Nouveaux benzamides substitues utilisables comme medicaments
FR2453145A1 (fr)
FR2372810A1 (fr) Nouvelles aminoalcoylimidazolidinones, procedes pour leur preparation et leur utilisation en tant que medicaments
MC1213A1 (fr) Derives imidazoliques utiles comme medicaments
FR2387954A1 (fr) Derives de mercaptoalkylsulfonylproline et composes apparentes, et leur utilisation comme medicaments
FR2359115A1 (fr) Derives tetraalkyles de bis-cyclohexylamines et leur preparation
FR2383922A1 (fr) Nouvelles 4-acylamino-phenyl-ethanolamines, procede pour leur preparation et leur utilisation en tant que medicaments
IT1097258B (it) Prodotto cosmetico antisolare per il campo uv-a
FR2377392A1 (fr) Nouveaux medicaments derives de la meta-trifluoromethyl-phenylpiperazine
FR2357553A1 (fr) Procede de preparation de benzothiazoles
FR2363556A1 (fr) Nouvelles phenylethylamines, leur preparation et leur utilisation en tant que medicaments
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
BE866057A (fr) Derives de l'aniline utilisables comme medicament
BE865624A (fr) Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
FR2390454A1 (fr) 17-alkylthio (et arylthio)-1', 2', 3', 4'-tetrahydroandrosteno(16 a, 17 a-b)naphtalenes et derives, et leur utilisation comme medicaments
FR2421900A1 (fr) Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques
FI781330A (fi) Foerbaettrad begraensare foer medelstroemmaengden av en straole
FR2427335A1 (fr) Derives du 5-nitro-imidazole, leur preparation et leurs utilisations comme medicaments antiprotozoaires
FR2385707A1 (fr) 3-amino-6,7-dialcoxy-1h-1,2,4-benzothiadiazine-1-oxydes 1-substitues et leur utilisation comme medicaments
IT1097259B (it) Prodotto cosmetico antisolare per il campo uv-a
FR2385670A1 (fr) Procede de preparation de 2,2-dimethylolalcanals
FR2385711A1 (fr) G,g-dialkyl-d-valerolactones, utilisables dans des parfums
FR2443457A1 (fr) Derives de 1-phenyl-2-amino-1-propanol, leur procede de preparation et leur utilisation comme medicaments
FR2381767A1 (fr) Pyrroloquinoxalinones et diones subsituees et leur utilisation comme medicaments